S3-Guideline “Exocrine Pancreatic Carcinoma” 20071 ... - DGVS
S3-Guideline “Exocrine Pancreatic Carcinoma” 20071 ... - DGVS
S3-Guideline “Exocrine Pancreatic Carcinoma” 20071 ... - DGVS
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
450<br />
Leitlinie<br />
The methodologic recommendations of the AWMF on the preparation<br />
of guidelines (http://www.awmf-leitlinien.de), the<br />
guideline manual of the Medical Center of Quality in Medicine<br />
(http://www.aezq.de), and the German Instrument on Methodologic<br />
<strong>Guideline</strong> Evaluation (http://www.delbi.de) were the<br />
basis for the organization of the guideline procedure. As is demonstrated<br />
in the following chapter (guideline report), the<br />
guideline fulfills the criteria of an evidence and consensusbased<br />
guideline (<strong>S3</strong>).<br />
This guideline is estimated to be valid for 3 years. If during this<br />
time important changes in care become evident, the coordination<br />
groups will decide whether individual topics or the complete<br />
guideline must be updated ahead of time.<br />
The preparation of the guideline was financially supported by<br />
the <strong>DGVS</strong> and the DKG. The work of the participants taking<br />
part in the consensus process and the resulting recommendations<br />
were not influenced by this support.<br />
This manuscript is the English version of the German guidelines<br />
that were published in the Zeitschrift für Gastroenetrologie<br />
in June 2007 [1].<br />
Organizational procedure and methodologic basis of<br />
the consensus process (guideline report)<br />
!<br />
Following the commission by the <strong>DGVS</strong> and the DKG, the organizational<br />
procedure for the guideline preparation was discussed<br />
with the chairman of the guideline commission, Prof. H.-K.<br />
Selbmann. Subsequent methodologic supervision was done by<br />
the vice chairman Dr. Ina Kopp. The guideline project was registered<br />
at the AWMF on July 4, 2005 (AWMF-Register-No. 032/<br />
010).<br />
Recruitment of participants<br />
To recruit the members of the steering committee (coordinators)<br />
presidents of the societies involved in diagnostics, therapy,<br />
and follow-up of pancreatic carcinoma were asked to<br />
name two representatives. After voting on the topics, the naming<br />
and invitation of task force members was performed together<br />
with the coordinators (l " Table 1). Participants were doctors<br />
from various care levels who work in hospitals and private<br />
practices. They represented the key disciplines that are relevant<br />
for pancreatic carcinoma: internal medicine (gastroenterology,<br />
hematology-oncology), surgery (visceral surgery), radiooncology,<br />
pathology, diagnostic radiology, palliative medicine,<br />
pain therapy, dietary medicine, psychotherapy-psychosomatics,<br />
laboratory medicine, and epidemiology. The patients’ representative<br />
was appointed by the Task Force of the Pancreatectomized<br />
Patients e. V. Dormagen.<br />
Organizational procedure<br />
Following the voting on the topics with the coordinators, the<br />
list of questions was generated and the search terms for the<br />
literature search were defined (time course l " Table 2). Afterwards<br />
the list of questions and the search terms were revised<br />
and amended by the task forces. A systematic literature<br />
search according to defined search terms was done in<br />
PubMed/Medline for the period from 1995 to May 2006 (inclusive).<br />
The search terms that were used are listed in the<br />
appendix. A total of 42345 citations were viewed (l " Table 3)<br />
and appendix (l " Table 10). 1409 were chosen according to<br />
the following criteria: investigations in humans, original arti-<br />
Adler G et al. <strong>S3</strong>-<strong>Guideline</strong> <strong>“Exocrine</strong> <strong>Pancreatic</strong>… Z Gastroenterol 2008; 46: 449–482<br />
Table 1 Task forces<br />
1. Risk factors/screening/risk groups<br />
chairmen<br />
S.C. Bischoff Universität Hohenheim, Lehrstuhl für Ernährungsmedizin<br />
und Prävention, Stuttgart<br />
S. Hahn Knappschaftskrankenhaus, Medizinische Universitätsklinik,<br />
Bochum<br />
R. Schmid Klinikum rechts der Isar der TU, II. Medizinische<br />
Klinik und Poliklinik, München<br />
members<br />
G. Adler Universitätsklinikum, Zentrum für Innere Medizin,<br />
Klinik für Innere Medizin I, Ulm<br />
A. Aschoff Universitätsklinikum, Klinik für Diagnostische und<br />
Interventionelle Radiologie, Ulm<br />
I. Bergheim Universität Hohenheim, Lehrstuhl für Ernährungsmedizin<br />
und Prävention, Stuttgart<br />
T. Gress Universitätsklinikum Giessen und Marburg GmbH,<br />
Klinik für Innere Medizin, SP Gastroenterologie,<br />
Endokrinologie und Stoffwechsel, Marburg<br />
V. Keim Universitätsklinikum, Medizinische Klinik und Poliklinik<br />
II, Leipzig<br />
M. Lerch Universitätsklinikum, Klinik und Poliklinik für Innere<br />
Medizin A, Greifswald<br />
J. Lüttges Klinikum Saarbrücken, Pathologisches Institut,<br />
Saarbrücken<br />
G. Nagel Universität Ulm, Institut für Epidemiologie, Ulm<br />
H. Rieder Universitätsklinikum, Institut für Humangenetik<br />
und Anthropologie, Düsseldorf<br />
2. Diagnostics<br />
chairmen<br />
H.-J. Brambs Universitätsklinikum, Klinik für Diagnostische und<br />
Interventionelle Radiologie, Ulm<br />
K. Schlottmann Katharinen-Hospital gGmbH, Innere Klinik I, Unna<br />
B. Wiedenmann CharitØ Universitätsmedizin, CharitØCentrum 13,<br />
Medizinische Klinik mit SP Hepatologie und Gastroenterologie,<br />
Campus Virchow, Berlin<br />
members<br />
M. Dobritz Klinikum rechts der Isar der TU, Institut für Rçntgendiagnostik,<br />
München<br />
P. Mçller Universitätsklinikum, Comprehensive Cancer<br />
Center, Institut für Pathologie, Ulm<br />
J. Mçssner Universitätsklinikum, Zentrum für Innere Medizin,<br />
Medizinische Klinik und Poliklinik II; Gastroenterologie<br />
und Hepatologie, Leipzig<br />
S.T. Post Universitätsklinikum gGmbH, Chirurgische Klinik,<br />
Mannheim<br />
S.N. Reske Universitätsklinikum, Klinik für Nuklearmedizin,<br />
Ulm<br />
J.F.Riemann Klinikum der Stadt Ludwigshafen am Rhein<br />
gGmbH, Medizinische Klinik C, Ludwigshafen<br />
T. Rçsch CharitØ Universitätsmedizin, CharitØCentrum 13,<br />
Medizinische Klinik mit SP Hepatologie und Gastroenterologie,<br />
Zentrale interdisziplinäre Endoskopie,<br />
Campus Virchow, Berlin<br />
A.-O. Schäfer Universitätsklinikum, Radiologische Universitätsklinik,<br />
Rçntgendiagnostik, Freiburg<br />
W. Uhl St. Josef-Hospital, Klinikum der Ruhr-Universität,<br />
Klinik für Chirurgie, Bochum<br />
C. Wagener Universitätsklinikum, Institut für Klinische Chemie/Zentrallaboratorien,<br />
Hamburg-Eppendorf<br />
3. Surgical therapy of pancreatic carcinoma (curative intention)<br />
chairmen<br />
J. Werner Universitätsklinikum, Chirurgische Klinik, Klinik<br />
für Allgemein-, Viszeral- und Transplantationschirurgie,<br />
Heidelberg<br />
W. Hohenberger Chirurgische Klinik mit Poliklinik der Friedrich-<br />
Alexander-Universität Erlangen-Nürnberg, Allgemeine,<br />
Bauch- und Thoraxchirurgie, Erlangen<br />
Downloaded by: Thieme Verlagsgruppe. Copyrighted material.